RARE-23. HIGH DOSE METHOTREXATE WITH OR WITHOUT VINCRISTINE FOR PRIMARY CNS LYMPHOMA, THE OHIO STATE UNIVERSITY EXPERIENCE

OBJECTIVES: 1) Determine the response rate (RR) after chemotherapy with high-dose methotrexate with or without vincristine in patients with primary CNS lymphoma. 2) Determine the difference in adverse effects with the use of vincristine. 3) Determine the difference in progression-free survival (PFS)...

Full beskrivning

Sparad:
Bibliografiska uppgifter
I publikationen:Neuro Oncol
Huvudupphovsmän: Freeman, Tracelyn, Legasto, Carlo, Schickli, Alex, McLaughlin, Eric, Giglio, Pierre, Puduvalli, Vinay, Gonzalez, Javier
Materialtyp: Artigo
Språk:Inglês
Publicerad: Oxford University Press 2019
Ämnen:
Rare Tumors
Länkar:https://ncbi.nlm.nih.gov/pmc/articles/PMC6847098/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/noz175.946
Taggar: Lägg till en tagg
Inga taggar, Lägg till första taggen!

Liknande verk